OBIO (OBIO) Stock Price & Analysis
OBIO (OBIO) rose 6.89% to USD 5.43 as of September 9, 2026 at 11:26 UTC, according to Nexqual real-time market data.
OBIO last closed at USD 5.43; the session ranged USD 4.8–5.51 on volume of 358,996 shares. Market capitalization is —, with a 52-week range of USD 2.2–5.78 (NGM). Source: Nexqual, September 9, 2026 at 11:26 UTC.
Key Statistics (as of September 9, 2026 at 11:26 UTC)
| Price | USD 5.43 |
|---|---|
| Change | ▲ 6.89% (up) |
| Previous Close | USD 5.43 |
| Open | USD 5.43 |
| Day Range | USD 4.8 – 5.51 |
| 52-Week Range | USD 2.2 – 5.78 |
| Volume | 358,996 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (OBIO)
Nexqual's technical model rates OBIO "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 11:26 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 66.04 (neutral) |
| vs SMA50 | Above (USD 4.4) |
| MACD | 0.21 (positive) |
From OBIO's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | USD 2.1 | ▲ 1.94% |
| CBUS | Cibus, Inc. | USD 1.61 | ▲ 1.9% |
| ZURA | Zura Bio Limited | USD 6.13 | ▲ 4.25% |
| OABI | OmniAb, Inc. | USD 4.24 | ▼ 10.74% |
| TLSI | TriSalus Life Sciences, Inc. | USD 4.73 | ▼ 5.02% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 11:26 UTC. This page is informational and not investment advice.